Finally, we took a translational approach using the “ROC” register to evaluate whether LTα3 had a role in established RA by assessing the outcome of a therapeutic switch from anti-TNF Ab to ETA, i.e., comparing neutralization of TNF alone with neutralization of TNF + LTα3. The gene discussed is TNF; the disease is rheumatoid arthritis.